| |
|
|
|
|
|
|
|||
|
Blood, 15 March 2007, Vol. 109, No. 6, pp. 2453-2460. Prepublished online as a Blood First Edition Paper on November 9, 2006; DOI 10.1182/blood-2006-08-040444.
Submitted August 11, 2006
Department of Pediatrics, University Hospital Muenster, Muenster, Germany * Corresponding author; email: rothj{at}uni-muenster.de.
Activated phagocytes express considerable amounts of
MRP8 and MRP14, two calcium-binding S100-proteins
forming stable heterodimers that are specifically
secreted at inflammatory sites in many diseases. We
previously reported that treatment of human
microvascular endothelial cells with purified MRP8/MRP14
leads to loss of endothelial cell-contacts. In this
study, we demonstrate that MRP8/MRP14-complexes
furthermore trigger cell death of endothelial cells
after the onset of cell detachment. Morphological
analysis of dying endothelial cells revealed
characteristic features of both, apoptosis and necrosis.
Furthermore, MRP8/MRP14 induced apoptotic caspase-9 and -
3 activation, DNA fragmentation and membrane
phosphatidylserine exposure in target cells. These
events were independent of death receptor signaling and
in part controlled by a mitochondrial pathway.
Consistently, overexpression of anti-apoptotic Bcl-2
abrogated caspase activation and externalization of
phosphatidylserine, however, MRP8/MRP14 still induced
plasma membrane damage and even DNA fragmentation. Thus,
our results demonstrate that MRP8/MRP14 triggers cell
death via caspase-dependent as well as -independent
mechanisms. Excessive release of cytotoxic MRP8/MRP14 by
activated phagocytes might therefore present an
important molecular pathomechanism contributing to
endothelial damage during vasculitis and other
inflammatory diseases.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||